behavior testing

February 27, 2025

Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer’s disease mice

Abstract Background: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline and behavior impairments. Despite recent approvals of…

February 28, 2023

Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice

Abstract In recent years, there has been growing evidence that cannabinoids have promising medicinal and pharmacological effects. However, the growing…